Imagen de Portada

HOXC 6 Activates BCAT 1 Expression to Promote Oral Cancer Development

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Meiheriban Tuerhong, Zaynure Wubulihasimu, Bo Xu, Ling Zhang
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Oral Diseases
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cancer Hallmarks Expression in Oral Leukoplakia: Systematic Review and Meta‐Analysis
por: I. González‐Ruiz, et al.
Publicado: (2025)

BCAT1 promotes cell proliferation, migration, and invasion via the PI3K‐Akt signaling pathway in oral squamous cell carcinoma
por: Zhenying Yuan, et al.
Publicado: (2024)

Oral Cancer in Asia
por: Saman Warnakulasuriya, et al.
Publicado: (2025)

Porphyromonas gingivalis Promotes Oral Squamous Cell Carcinoma Progression by Modulating Autophagy
por: Keyong Yuan, et al.
Publicado: (2024)

MR1 ‐Mediated Activation of Mucosal‐Associated Invariant T Cells by Oral Lichen Planus‐Associated Fibroblasts
por: Xiaoli Wu, et al.
Publicado: (2026)

Effects of Public Disclosure of a Japanese Celebrity's Oral Cancer: Trends in Oral Cancer Diagnoses
por: Shihoko Koyama, et al.
Publicado: (2025)

Stromal Prognostic Markers for Oral Cancer: An Update
por: Everton Freitas de Morais, et al.
Publicado: (2025)

Speech and Swallowing Disorders in Adolescent and Young Adults With Oral Cavity Cancer
por: Wei Deng, et al.
Publicado: (2025)

Body Mass Index as an Indicator of Survival in Oral Cancer
por: Deysimara de Cássia Santos, et al.
Publicado: (2024)

NUTF2 Promotes Proliferation of Oral Squamous Cell Carcinoma Through PI3K/AKT Signaling Pathway
por: Zhihong Chen, et al.
Publicado: (2025)

Association Between Oral Lichen Planus and Non‐Oral Cancers: A Multicentre Case–Control SIPMO Study
por: Gioele Gioco, et al.
Publicado: (2025)

Microbiome Signatures and Dysbiotic Patterns in Oral Cancer and Precancerous Lesions
por: Cheng‐Chieh Yang, et al.
Publicado: (2025)

Patient and System Barriers to Early Diagnosis of Oral Cancer in the UK
por: Emmanuel Kwateng Drokow, et al.
Publicado: (2025)

An Analysis of the Timeline to Diagnosis and Treatment in Oral Cavity and Oropharynx Cancer
por: Josefina Martínez‐Ramírez, et al.
Publicado: (2025)

Cultural Competence: An Overlooked Factor in the Early Diagnosis of Oral Cancer?
por: Danyel Elias da Cruz Perez, et al.
Publicado: (2026)

Mortality Trends and Projections for Oral, Lip, and Oropharyngeal Cancers in Brazil
por: Victor Zanetti Drumond, et al.
Publicado: (2026)

Preoperative Staging in Oral Cavity Cancer: Nationwide Practice and Concordance With Pathology
por: Hanneke Doremiek van Oorschot, et al.
Publicado: (2025)

Emerging Preclinical and Clinical Evidence on the Impact of Phytochemicals in Oral Cancer Metastasis
por: Murugesan Amirtha Varshini, et al.
Publicado: (2025)

Impact of the International Tumor Budding Consensus Conference Recommendations in Oral Cancer
por: Katerina Kopecka, et al.
Publicado: (2024)

Comment on “An Analysis of the Timeline to Diagnosis and Treatment in Oral Cavity and Oropharynx Cancer”
por: João Alberto de Almeida Gonçalves, et al.
Publicado: (2026)

Comment on “Patient and System Barriers to Early Diagnosis of Oral Cancer in the UK ”
por: Chenglu Ruan, et al.
Publicado: (2026)

CCL19 + Fibroblasts Promote Tertiary Lymphoid Structure in Oral Lichen Planus: A Retrospective Study
por: Yi‐Rao Lai, et al.
Publicado: (2025)

Tumor‐Stroma Ratio, Infiltrating Lymphocytes, and Their Combined Profiles in Oral Cancer Prognosis
por: Michal Herman, et al.
Publicado: (2025)

Accuracy of ChatGPT‐4 Plus in Providing Information on Oral Cancer Management
por: Busra Yilmaz, et al.
Publicado: (2025)

Authors' Reply: “An Analysis of the Timeline to Diagnosis and Treatment in Oral Cavity and Oropharynx Cancer”
por: Josefina Martínez‐Ramírez, et al.
Publicado: (2026)

Comment on “Preoperative Staging in Oral Cavity Cancer: Nationwide Practice and Concordance With Pathology”
por: Ali Abasi, et al.
Publicado: (2026)

Primary Care Referral Delays in Oral Cancer Diagnosis: A Meta‐Analysis
por: Juan Manuel Seoane Romero, et al.
Publicado: (2024)

Metabolic Reprogramming and GM ‐ CSF Secretion in Areca Nut‐Activated Fibroblasts Drive Oral Precancer Progression
por: Yen‐Yun Wang, et al.
Publicado: (2026)

LINC01106 Facilitates Oral Squamous Cell Carcinoma Progression by Sponging miRNA‐449a and Regulating MYC Expression
por: Jiayu Chen, et al.
Publicado: (2026)

Time to Treatment Initiation of Oral Cancer: Impact of a National Policy in Midwest Brazil
por: Mary Anne de Souza Alves França, et al.
Publicado: (2025)

Non‐Anticoagulant Heparin: An In Vitro Investigation of a Novel Therapeutic Approach for Oral Cancer
por: S. A. Hamza, et al.
Publicado: (2025)

Correction to “Proliferative Ability and Accumulation of Cancer Stem Cells in Oral Submucous Fibrosis Epithelium”
Publicado: (2025)

Diagnosis of Oral Cancer With Deep Learning. A Comparative Test Accuracy Systematic Review
por: Michele Nieri, et al.
Publicado: (2025)

Non‐smoking and Non‐drinking Oral Cancer Patients Are at Higher Risk of Second Primary Tumours
por: Pepijn J. P. van der Aa, et al.
Publicado: (2024)

Development and Validation of an Oral Lichen Planus Daily Management Questionnaire: A KAP Evaluation
por: Xiaofen Lin, et al.
Publicado: (2026)

Authors' Reply: “Surgical Treatment Compared With ‘Wait and See’ in Patients Affected by Oral Leukoplakia to Prevent Oral Cancer: Preliminary Data From a Multicenter Randomized Controlled Trial”
por: Niccolò Lombardi, et al.
Publicado: (2024)

Authors' Reply: “Hydroxychloroquine Is Effective in Oral Lichen Planus”
por: Yulang Xie, et al.
Publicado: (2024)

Temporal Trends of Oral and Oropharyngeal Cancer Records in Brazil From 2019 to 2023 and Factors Impacting Treatment Delay
por: Débora Rosana Alves Braga Silva Montagnoli, et al.
Publicado: (2025)

Authors' Reply “Non‐Smoking and Non‐Drinking Oral Cancer Patients Are at Higher Risk of Second Primary Tumours”
por: Pepijn J. P. van der Aa, et al.
Publicado: (2025)

The Paradoxical Influence of Hyperthermia on Progression‐Free Survival in Recurrent/Metastatic Oral Cancer Treated With Immune Checkpoint Inhibitors
por: Shogo Kikuta, et al.
Publicado: (2025)